Testing effectiveness (Phase 2)Study completedNCT00666588
What this trial is testing
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Who this might be right for
Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloblastic Leukemia With Maturation (M2)+19 more
National Cancer Institute (NCI) 52